 | Up a level |
2022
Franklin, Cindy 
ORCID: 0000-0001-9142-5423, Mohr, Peter, Bluhm, Leonie, Grimmelmann, Imke, Gutzmer, Ralf, Meier, Friedegund ORCID: 0000-0003-4340-9706, Garzarolli, Marlene, Weichenthal, Michael ORCID: 0000-0002-9060-4961, Pfoehler, Claudia, Herbst, Rudolf ORCID: 0000-0002-4238-9486, Terheyden, Patrick, Utikal, Jochen, Ulrich, Jens, Debus, Dirk, Haferkamp, Sebastian, Kaatz, Martin, Forschner, Andrea, Leiter, Ulrike, Nashan, Dorothee, Kreuter, Alexander, Sachse, Michael, Welzel, Julia, Heinzerling, Lucie, Meiss, Frank, Weishaupt, Carsten, Gambichler, Thilo, Weyandt, Gerhard, Dippel, Edgar, Schatton, Kerstin, Celik, Eren, Trommer, Maike, Helfrich, Iris, Roesch, Alexander, Zimmer, Lisa ORCID: 0000-0002-3680-3521, Livingstone, Elisabeth, Schadendorf, Dirk, Horn, Susanne and Ugurel, Selma
(2022).
Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG.
J. Immunother. Cancer, 10 (6).
LONDON:
BMJ PUBLISHING GROUP.
ISSN 2051-1426
2021
Persa, Oana D., Schatton, Kerstin, Ruebben, Albert, Berking, Carola, Erdmann, Michael, Schlaak, Max, Mauch, Cornelia and Steeb, Theresa (2021). Risk Factors for Relapse after Intentional Discontinuation of Immune Checkpoint Inhibitors in Melanoma Patients. J. Immunother., 44 (6). S. 239 - 242. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1537-4513
2020
Leiter, Ulrike, Loquai, Carmen, Reinhardt, Lydia, Rafei-Shamsabadi, David, Gutzmer, Ralf, Kaehler, Katharina, Heinzerling, Lucie, Hassel, Jessica C., Glutsch, Valerie, Sirokay, Judith, Schlecht, Nora, Rubben, Albert, Gambichler, Thilo, Schatton, Kerstin, Pfoehler, Claudia, Franklin, Cindy, Terheyden, Patrick, Haferkamp, Sebastian, Mohr, Peter, Bischof, Lena, Livingstone, Elisabeth, Zimmer, Lisa, Weichenthal, Michael, Schadendorf, Dirk, Meiwes, Andreas, Keim, Ulrike, Garbe, Claus, Becker, Jurgen Christian and Ugurel, Selma (2020). Immune checkpoint inhibition therapy for advanced skin cancer in patients with concomitant hematological malignancy: a retrospective multicenter DeCOG study of 84 patients. J. Immunother. Cancer, 8 (2). LONDON: BMJ PUBLISHING GROUP. ISSN 2051-1426